2023
Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study
Shah S, Markatia Z, Watane A, Feldman A, Shah L, Sridhar J. Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study. Current Opinion In Ophthalmology 2023, 34: 218-225. PMID: 36866850, DOI: 10.1097/icu.0000000000000944.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsBevacizumabDiabetic RetinopathyEndothelial Growth FactorsHumansIntravitreal InjectionsOphthalmologistsPractice Patterns, Physicians'RanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsReview Literature as TopicUnited StatesVascular Endothelial Growth Factor AVisual AcuityConceptsDiabetic macular edemaClinical trial publicationsAflibercept injectionsTrial publicationsAntivascular endothelial growth factor medicationsTreatment of DMEAnti-VEGF agentsGrowth factor usageMacular edemaVEGF agentsLabel bevacizumabT studyTrial resultsBevacizumabYear of publicationMean proportionAverage numberPhysiciansFactor usageTreatmentInjectionIndicationsYearsAfliberceptMedications
2021
Representation of Women in Ophthalmology Receiving Private Industry Funding 2015-2018
Patel M, Salazar H, Watane A, Yannuzzi N, Bounds G, Reddy A, Bakri S, Sridhar J. Representation of Women in Ophthalmology Receiving Private Industry Funding 2015-2018. American Journal Of Ophthalmology 2021, 235: 56-62. PMID: 34509432, PMCID: PMC8863585, DOI: 10.1016/j.ajo.2021.09.001.Peer-Reviewed Original ResearchTRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN–INDUSTRY INTERACTIONS
Watane A, Kalavar M, Yannuzzi NA, Kuriyan AE, Sridhar J. TRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN–INDUSTRY INTERACTIONS. Retina 2021, 41: 1754-1761. PMID: 33315816, PMCID: PMC8190160, DOI: 10.1097/iae.0000000000003081.Peer-Reviewed Original ResearchA 5-Year Analysis of Physician-Industry Interactions, Physician Gender, and Anti-VEGF Use in US Ophthalmologists
Watane A, Kalavar M, Patel M, Yannuzzi N, Vanner EA, Kuriyan AE, Sridhar J. A 5-Year Analysis of Physician-Industry Interactions, Physician Gender, and Anti-VEGF Use in US Ophthalmologists. Seminars In Ophthalmology 2021, 36: 804-811. PMID: 34024227, DOI: 10.1080/08820538.2021.1922710.Peer-Reviewed Original ResearchDemographic Variations in Patient Populations and Regional Distributions Between Male and Female Ophthalmologists in the United States: Cross-Sectional Analysis
Kalavar M, Watane A, Cavuoto KM, Vanner EA, Sridhar J. Demographic Variations in Patient Populations and Regional Distributions Between Male and Female Ophthalmologists in the United States: Cross-Sectional Analysis. Seminars In Ophthalmology 2021, 36: 633-640. PMID: 33616481, DOI: 10.1080/08820538.2021.1891264.Peer-Reviewed Original ResearchMeSH KeywordsAgedCross-Sectional StudiesDemographyFemaleHumansMaleMedicareOphthalmologistsPractice Patterns, Physicians'United StatesConceptsFemale ophthalmologistsCross-sectional analysisPatient demographicsWhite patientsFemale patientsPatient populationPhysician genderMedicare beneficiariesAverage ageDemographic dataOphthalmologistsPractice sizeFemale beneficiariesMedicare PhysicianMedical schoolsPatientsYounger beneficiariesHigher proportionSmall proportionRegional distribution